Gene |
Time course graph |
Description |
Treatment |
15min |
30min |
1min |
2min |
4min |
8min |
20min |
Agpat6 | | 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) (Agpat6), mRNA [NM_018743] |
KLA | 1.14 |
1.08 |
1.21 |
1.15 |
1.17 |
1.25 |
1.50 |
| ATP | 1.05 |
1.02 |
0.91 |
0.91 |
1.11 |
1.42 |
1.26 |
| ATP+KLA | 1.16 |
1.17 |
0.96 |
0.87 |
1.00 |
1.40 |
1.35 |
|
Cdipt | | CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase) (Cdipt), mRNA [NM_026638] |
KLA | 0.75 |
0.74 |
0.71 |
0.67 |
0.79 |
0.87 |
1.15 |
| ATP | 1.07 |
1.03 |
0.76 |
0.81 |
0.75 |
0.77 |
1.18 |
| ATP+KLA | 0.82 |
0.72 |
0.51 |
0.53 |
0.51 |
0.72 |
1.22 |
|
Cds1 | | CDP-diacylglycerol synthase 1 (Cds1), mRNA [NM_173370] |
KLA | 2.81 |
2.96 |
3.62 |
3.43 |
3.28 |
1.96 |
0.97 |
| ATP | 1.07 |
1.05 |
0.86 |
0.90 |
0.78 |
0.82 |
1.17 |
| ATP+KLA | 2.84 |
2.92 |
2.34 |
2.04 |
1.61 |
1.01 |
0.97 |
|
Chkb | | choline kinase beta (Chkb), mRNA [NM_007692] |
KLA | 0.70 |
0.72 |
0.70 |
0.66 |
0.86 |
0.79 |
0.78 |
| ATP | 0.96 |
0.86 |
0.72 |
0.86 |
1.35 |
1.43 |
0.95 |
| ATP+KLA | 0.68 |
0.55 |
0.52 |
0.61 |
1.24 |
1.30 |
1.10 |
|
Chpt1 | | choline phosphotransferase 1 (Chpt1), mRNA [NM_144807] |
KLA | 1.16 |
1.18 |
1.24 |
1.15 |
1.16 |
1.09 |
1.23 |
| ATP | 1.01 |
1.05 |
1.16 |
1.09 |
0.98 |
0.96 |
0.98 |
| ATP+KLA | 1.20 |
1.15 |
1.13 |
1.18 |
1.17 |
1.33 |
1.25 |
|
Dgkz | | diacylglycerol kinase zeta (Dgkz), mRNA [NM_138306] |
KLA | 0.21 |
0.22 |
0.23 |
0.29 |
0.56 |
1.23 |
1.39 |
| ATP | 1.08 |
1.25 |
0.90 |
1.22 |
0.85 |
0.57 |
1.44 |
| ATP+KLA | 0.23 |
0.22 |
0.18 |
0.31 |
0.60 |
0.80 |
1.45 |
|
Etnk1 | | gb|PREDICTED: Mus musculus ethanolamine kinase 1 (Etnk1), mRNA [XM_908334] |
KLA | 5.38 |
5.56 |
5.81 |
5.53 |
4.73 |
4.65 |
2.51 |
| ATP | 1.01 |
1.05 |
1.13 |
1.21 |
1.24 |
2.34 |
2.30 |
| ATP+KLA | 5.41 |
5.64 |
5.14 |
6.04 |
5.38 |
4.90 |
5.42 |
|
Gpam | | glycerol-3-phosphate acyltransferase, mitochondrial (Gpam), nuclear gene encoding mitochondrial protein, mRNA [NM_008149] |
KLA | 1.04 |
0.97 |
1.00 |
1.04 |
0.90 |
0.96 |
1.00 |
| ATP | 0.98 |
1.18 |
1.10 |
0.95 |
0.70 |
0.98 |
1.37 |
| ATP+KLA | 1.03 |
1.06 |
1.05 |
1.01 |
0.79 |
0.89 |
1.00 |
|
Pcyt1a | | 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930020C23 product:phosphate cytidylyltransferase 1, choline, alpha isoform, full insert sequence [AK163685] |
KLA | 0.63 |
0.65 |
0.76 |
0.82 |
0.87 |
1.04 |
0.67 |
| ATP | 1.00 |
1.10 |
0.81 |
1.07 |
2.85 |
1.72 |
1.60 |
| ATP+KLA | 0.64 |
0.63 |
0.48 |
0.97 |
2.62 |
2.63 |
1.66 |
|
Pcyt1a | | phosphate cytidylyltransferase 1, choline, alpha isoform (Pcyt1a), mRNA [NM_009981] |
KLA | 0.67 |
0.77 |
0.90 |
0.96 |
0.99 |
1.16 |
0.81 |
| ATP | 0.93 |
1.04 |
0.85 |
1.22 |
2.93 |
1.57 |
1.91 |
| ATP+KLA | 0.72 |
0.73 |
0.82 |
1.17 |
2.79 |
2.47 |
1.62 |
|
Pcyt2 | | phosphate cytidylyltransferase 2, ethanolamine (Pcyt2), mRNA [NM_024229] |
KLA | 0.58 |
0.57 |
0.56 |
0.46 |
0.49 |
0.42 |
0.54 |
| ATP | 0.97 |
0.94 |
1.03 |
0.99 |
0.70 |
0.66 |
1.11 |
| ATP+KLA | 0.59 |
0.58 |
0.60 |
0.54 |
0.43 |
0.34 |
0.45 |
|
Pemt | | phosphatidylethanolamine N-methyltransferase (Pemt), nuclear gene encoding mitochondrial protein, mRNA [NM_008819] |
KLA | 1.00 |
1.08 |
1.08 |
0.99 |
0.92 |
0.83 |
0.93 |
| ATP | 1.08 |
1.16 |
1.04 |
1.22 |
1.02 |
0.89 |
0.84 |
| ATP+KLA | 1.14 |
1.10 |
0.92 |
1.05 |
0.83 |
0.76 |
0.71 |
|
Pisd | | phosphatidylserine decarboxylase (Pisd), mRNA [NM_177298] |
KLA | 0.71 |
0.66 |
0.72 |
0.80 |
0.95 |
0.98 |
1.03 |
| ATP | 1.00 |
0.89 |
0.79 |
0.67 |
0.96 |
1.16 |
0.99 |
| ATP+KLA | 0.69 |
0.65 |
0.58 |
0.58 |
0.90 |
1.12 |
0.99 |
|
Pla2g1b | | phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] |
KLA | 1.00 |
1.01 |
1.01 |
1.11 |
1.00 |
1.28 |
1.00 |
| ATP | 0.98 |
1.03 |
1.09 |
1.03 |
1.01 |
1.02 |
1.04 |
| ATP+KLA | 0.93 |
0.94 |
1.01 |
1.00 |
0.94 |
1.09 |
1.07 |
|
Pld1 | | phospholipase D1 (Pld1), mRNA [NM_008875] |
KLA | 0.71 |
0.73 |
0.67 |
0.73 |
0.88 |
0.96 |
1.25 |
| ATP | 0.99 |
0.88 |
0.73 |
0.68 |
0.45 |
1.23 |
1.12 |
| ATP+KLA | 0.70 |
0.67 |
0.58 |
0.59 |
0.48 |
0.91 |
1.48 |
|
Pnpla3 | | patatin-like phospholipase domain containing 3 (Pnpla3), mRNA [NM_054088] |
KLA | 0.88 |
0.99 |
1.04 |
0.97 |
1.00 |
0.91 |
1.03 |
| ATP | 0.95 |
1.03 |
1.05 |
1.03 |
1.01 |
0.93 |
0.99 |
| ATP+KLA | 1.02 |
1.05 |
1.00 |
0.94 |
0.95 |
0.98 |
0.95 |
|
Ppap2a | | phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2, mRNA [NM_008903] |
KLA | 2.62 |
2.85 |
4.01 |
5.61 |
7.83 |
10.88 |
16.34 |
| ATP | 1.00 |
1.02 |
1.09 |
1.28 |
1.26 |
2.38 |
1.44 |
| ATP+KLA | 2.78 |
2.77 |
2.99 |
3.42 |
2.85 |
3.58 |
6.58 |
|
Ppap2b | | phosphatidic acid phosphatase type 2B (Ppap2b), mRNA [NM_080555] |
KLA | 2.73 |
2.72 |
2.65 |
2.39 |
1.07 |
1.48 |
3.26 |
| ATP | 0.99 |
0.97 |
1.60 |
2.76 |
18.64 |
27.23 |
9.19 |
| ATP+KLA | 2.69 |
2.80 |
4.36 |
4.20 |
14.33 |
15.32 |
17.91 |
|
Ppap2c | | phosphatidic acid phosphatase type 2c (Ppap2c), mRNA [NM_015817] |
KLA | 0.94 |
0.88 |
0.91 |
0.79 |
0.65 |
0.46 |
0.51 |
| ATP | 1.01 |
1.03 |
1.00 |
1.12 |
1.24 |
0.90 |
0.83 |
| ATP+KLA | 0.95 |
0.93 |
0.87 |
0.95 |
0.79 |
0.63 |
0.43 |
|
Ptdss1 | | phosphatidylserine synthase 1 (Ptdss1), mRNA [NM_008959] |
KLA | 0.88 |
0.95 |
0.96 |
0.86 |
0.88 |
0.92 |
1.05 |
| ATP | 1.02 |
1.05 |
0.90 |
1.08 |
0.99 |
0.93 |
1.17 |
| ATP+KLA | 0.95 |
0.93 |
0.81 |
0.85 |
0.67 |
0.83 |
1.10 |
|
Ptdss2 | | phosphatidylserine synthase 2 (Ptdss2), mRNA [NM_013782] |
KLA | 0.95 |
0.95 |
1.01 |
1.06 |
1.17 |
1.33 |
1.26 |
| ATP | 0.90 |
0.93 |
0.92 |
1.04 |
0.83 |
0.85 |
1.34 |
| ATP+KLA | 0.93 |
0.95 |
0.93 |
0.90 |
0.90 |
0.96 |
1.42 |
|